| Overview on Hepatitis C, treatment strategy, instrumental analysis of anti-HCV drugs AE Ibrahim, M Elhenawee, H Saleh, MM Sebaiy Pharm. Drug Innovat 2 (2), 1-8, 2021 | 6 | 2021 |
| Can medicinal mushrooms fight against sars-cov-2/covid-19? AK Mohiuddin Pharmacy and Drug Innovations 2 (1), 2, 2021 | 5 | 2021 |
| Recent update on transferosomes as transdermal drug delivery system J Rajkumar, AS Kumar, GJ Shahnawaz, A Sushmitha J Pharmacy and Drug Innovations 3 (2), 2021 | 5 | 2021 |
| Yellow Fungus emerging cases in India during the second wave of COVID-19 KT Hindustan Abdul Ahad1*, Haranath Chinthaginjala1, Mazin Aboobaida Abdalla ... Pharmacy and Drug Innovations 2 (4), 3, 2021 | 3* | 2021 |
| The health system in Sudan is characterised by heavy reliance on charging users at the point of access AM Omer Pharmacy and Drug Innovations 3 (3), 9, 2022 | 2 | 2022 |
| Anticonvulsant activity o f Tapinanthus dodoneifolius (DC.) Danser in chicks and mice: a potential source o f novel anticonvulsant agent MA Salaudeen, N Bello, MG Magaji, JO Akerele J. Pharm. Drug Innovations 3 (4), 1-6, 2022 | 2 | 2022 |
| Enalpril in Covid 19: A Possible Role Beyond Hypertension” K Ravishankar, GVN Kiranmayi J Pharmacy and Drug Innovations 2 (5), 2021 | 2 | 2021 |
| The efficiency of inefficiency: medicine distribution in Sudan AM Omer Universal Journal of Pharmaceutical Research 3 (2), 47-57, 2018 | 1 | 2018 |
| Through privatisation, government is not evading its responsibility of providing health-care to the inhabitants AM Omer Clinical Medicine Insights 3 (4), 343-356, 2022 | | 2022 |
| EL-Ghwas, Abdel-Nasser A. Zohri, Ghoson M. Daba (2022) Biotechnological Application of Citric Acid and Kojic Acid Produced by Fungi”. J Pharmacy and Drug Innovations, 3 (5 … WA Elkhateeb, E Dina doi. org/03.2022/1.1055, 2022 | | 2022 |
| The Roseate Tendrils-Colloid Cyst A Bajaj J Pharmacy and Drug Innovations 3 (5), 2022 | | 2022 |
| Marine endophytes a natural novel source for a treasure of bioactive compounds GMD Waill A. Elkhateeb* Pharmacy and Drug Innovations 3 (5), 6, 2022 | | 2022 |
| The Choleretic Activity of Black Seeds: Healthy Herbs SM Humaira Mahmood1, Seema Shah Murad2, Saima Masood3, Aneel Kapoor4, Asia ... Pharmacy and Drug Innovations 3 (4), 4, 2022 | | 2022 |
| Clinical pharmacology of imipenem GM Pacifici Pharmacy and Drug Innovations 3 (4), 8, 2022 | | 2022 |
| Clinical pharmacology of metoclopramide in infants and children GM Pacifici Pharmacy and Drug Innovations 3 (3), 5, 2022 | | 2022 |
| The Antı-Inflammatory Meroterpenes S Avunduk J Pharmacy and Drug Innovations 3 (4), 2022 | | 2022 |
| The Significant Risk Factor for Chronic Disease in Benghazi-Libya NHSB Hana A Habib Saad1*, Nazik. M. Ali hamad2, Wedad Abdullah3, Asma ... Pharmacy and Drug Innovations 3 (4), 6, 2022 | | 2022 |
| Only Pharmacy-and-Drug-Innovations Can Steady-Reopen Different Research-Educational-Institutions Immunization Against ‘Future A to Z Diseases’: Advanced Scientific-Community … 2* Subhas Chandra Datta1 Pharmacy and Drug Innovations 3 (3), 10, 2022 | | 2022 |
| Next Generation Probiotics: An Extended Arena of Probiotic Science”. J Pharmacy and Drug Innovations, 3 (3); DOI: http S Das, BK Bhattacharyya doi. org/03.2022/1.1043, 2022 | | 2022 |
| Prospective Study of Antibiotics Utilization in Pulmonology Department RM Sudireddy Rajini1*, B.S.Venkateswarlu2 Pharmacy and Drug Innovations 3 (3), 6, 2021 | | 2021 |
